loader image
Juices
  • QUINCE JUICE

    100% NATURAL PRODUCT!

    Quince juice promotes the removal of cholesterol from the organism, it is recommended to atherosclerosis, juice helpful for gastritis, hypertension, gallbladder disease and kidney as potassium, contained in it, releases the body from water and table salt.

    Effect: regulating the activity of the gastrointestinal tract.

  • TOMATO JUICE

    100% NATURAL PRODUCT!

    Note that fresh tomato pulp can fall down, so the upper part of the juice becomes lighter – a confirmation of naturalness of tomato juice.

    Tomato juice improves removable processes, is rich in vitamins, salts, minerals and protects cells from damage, stimulates the formation of connective tissue, increases the synthesis of hormones, restores the activity of the nervous system, promotes making of gastric juice, improves the heart, contains a lot of potassium, a dietary product.

    Effect: Antibacterial, anti-inflammatory, vascular cordial, diuretic.

    Restrictions: gallstone disease in which you should limit the receiving of juice.

  • CHERRY JUICE

    Cherry juice improves blood composition, strengthens vascular walls, relieves inflammation, rejuvenates the body, improves removable process, improves appetite, is used as expectorant.

    Effect: regulating the activity of the gastrointestinal tract.

    Restriction: In case of gastric ulcer and elevated acidity is better not to use.

  • PEACH JUICE

    100% NATURAL PRODUCT!

    Note that the pulp of fresh peaches can fall down, so the upper part of the juice becomes lighter – a confirmation of naturalness of the peach juice.

    Peach juice improves digestion. It’s recommended for arrhythmia, anaemia, it has calming effect on stomach with intensification of gastritis and other diseases. Vitamins contained in it, help the body adapt to the adverse external conditions.

  • DOGROSE JUICE

    100% NATURAL PRODUCT!

    Dogrose juice especially in large quantities provides vitamins – C, helps in the decomposition of salts, their removal from the body, used in kidney and chronic lung diseases, strengthens the immune system.

  • RASPBERRY JUICE

    100% NATURAL PRODUCT!

    Raspberry juice contains a large number of group vitamins, especially vitamin rich – C. What helps the body fight the severe environment. Enhances immune system, recommended for respiratory diseases.

  • CORNEL (DOGWOOD) JUICE

    100% NATURAL PRODUCT!

    Cornel (dogwood) juice improves blood composition, strengthens vascular walls, relieves inflammation, rejuvenates the body, improves removable process, improves appetite, is used as expectorant.

    Restriction: In case of gastric ulcer and increased acidity is better not to use.

  • POMEGRANATE JUICE

    100% NATURAL PRODUCT!

    Pomegranate juice stimulates appetite, is recommended for cardio – vascular diseases. Used as a recreation stuff and improves the recovery processes in the body after illness and surgery.

    Effect: strengthens blood vessels, purifies the organism.

  • APPLE JUICE

    100% NATURAL PRODUCT!

    Apple juice strengthens the cardio – vascular system and stimulates mental activity, removes from the body salts of heavy metals. Cleanses the body of toxins, improves the respiratory system. In apple juice contains pectin, acids, promoting digestion. Juice increases resistance to colds and infectious diseases.

    Effect: vascular strengthening, purifying.

  • GRAPE JUICE

    100% NATURAL PRODUCT!

    Grape juice – one of the most important and most valuable in the food and dietary component for power . The main grape juice sugar – glucose and fructose – absorbed by the body itself. Malic and tartaric acids are responsible for the diuretic properties of the juice. It is also very valuable is the presence in the juice of grapes biologically active substances and vitamins. Due to the large amount of potassium grape juice , like grape, is useful for people who are prone to cardiovascular diseases.

MAKE A STEP TOWADS TO

LONGEVITY!

GET IN TOUCH WITH US

    4+2=

     

    Global Longevity Disclaimer

    Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

    Potential investors should note that participation in the Global Longevity Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Potentially interested parties should note that participation in the Global Longevity project is subject to limitations imposed by applicable securities laws in various jurisdictions.

    Potential investors should note that participation in the Global Longevity project Sale is subject to limitations imposed by applicable securities laws in various jurisdictions. The following does neither constitute an offer to buy or to subscribe for the Global Longevity project. Investors should make their decision to buy or to subscribe to Global Longevity project.

    Investors are furthermore advised to consult their bank or financial adviser before making any investment decision. This publication may contain specific forward-looking statements, e.g. statements including terms like “believe”, assume”, “expect”, “forecast”, “project”, “may”, “could”, “might”, “will” or similar expressions. Such forward-looking statements are subject to known and unknown risks, uncertainties and other factors which may result in a substantial divergence between the actual results, financial situation, development or performance of the company and those explicitly or implicitly presumed in these statements.

    Against the background of these uncertainties, readers should not rely on forward-looking statements. Global Longevity project assumes no responsibility to update forward-looking statements or to adapt them to future events or developments. The information contained herein shall not constitute an offer to sell or the solicitation of an offer to buy, in any jurisdiction in which such offer or solicitation would be unlawful prior to registration, exemption from registration or qualification under the securities laws of any jurisdiction.

    The Global Longevity project are not for sale and distribution, directly or indirectly, in or into the United States (including its territories and dependencies, any state of the United States and the District of Columbia), Canada, Japan, Australia, North Korea, Iran, Myanmar, Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde, Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction into which the same would be unlawful.

    This announcement does not constitute or form a part of any offer or solicitation to purchase, subscribe for or otherwise acquire securities in the United States, Canada, Japan, Australia, North Korea, Iran, Myanmar,Afghanistan, Angola, Aruba, Bangladesh, Belarus, Benin, Bhutan, Bolivia, Botswana, Brunei Darussalam, Burkina Faso, Bosnia, Burundi, Cambodia, Cameroon, Cape Verde,Central Africa republic, Chad, Comorros, Congo, Congo Democratic republic, Cuba, Cote d’Ivoire, Djibouti, Dominica, Ecuador, El Salvador, Equatorial Guinea, Eritrea, Ethiopia, Gabon, Gambia, Ghana, Guatemala, Guyana, Guinea, Guinea Bissau, Haiti, Honduras, Iraq, Jordan, Kenya, Kyrgyz Republic, Laos People’s Republic, Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, Mauritania, Micronesia, Moldova, Mongolia, Mozambique, Nauru, Nepal, New Caledonia, Nicaragua, Niger, Nigeria, Niue, Oman, Pakistan, Palestinian Areas, Papua New Guinea, Reunion, Rwanda, Samoa, Sao Tome and Principe, Senegal, Sierra Leone, Somalia, South Georgia, Sudan, Sri Lanka, Suriname, Syria, Swaziland, Tajikistan, Tanzania, Timor, Togo, Tonga, Tunisia, Turkmenistan, Uganda, Uzbekistan, Venezuela, Western Sahara, Yemen, Zambia, Zimbabwe or any jurisdiction in which such an offer or solicitation is unlawful.

    The Global Longevity project will not be registered under the US Securities Act of 1933, as amended or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, taken up, exercised, resold, renounced, transferred or delivered, directly or indirectly, within the United States.

    The Global Longevity project have not been approved or disapproved by the US Securities and Exchange Commission, any state’s securities commission in the United States or any US regulatory authority, nor have any of the foregoing authorities passed upon or endorsed the merits of the offering of the Global Longevity project or the accuracy or adequacy of this announcement. Any representation to the contrary is a criminal offence in the United States. The information contained herein does not constitute an offer of securities to the public in the United Kingdom. No prospectus offering securities to the public will be published in the United Kingdom.

    This document is only being distributed to and is only directed at (i) persons who are outside the United Kingdom or (ii) to investment professionals falling within article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (the “Order”) or (iii) high net worth entities, and other persons to whom it may lawfully be communicated, falling within article 49(2)(a) to (d) of the Order (all such persons together being referred to as “relevant persons”). The Global Longevity project are only available to, and any invitation, offer or agreement to subscribe, purchase or otherwise acquire such the Global Longevity project will be engaged in only with, relevant persons.

    Any person who is not a relevant person should not act or rely on this document or any of its contents. Any offer of securities to the public that may be deemed to be made pursuant to this communication in any EEA Member State that has implemented Directive 2003/71/EC (together with any applicable implementing measures in any Member State, the “Prospectus Directive”) is only addressed to qualified investors in that Member State within the meaning of the Prospectus Directive.